考虑做ICL晶体植入术摘掉眼镜?很多高度近视的朋友在咨询时都会问：“我度数这么高，是不是用的晶体特别贵?” 今天就来揭秘ICL晶体的定价逻辑，看完你就心里有数了! ICL(Implantable Collamer Lens)，即可植入式隐形眼镜，因其矫正范围广、视觉质量高、可逆性强等 ...

Mizuho has downgraded STAAR Surgical (NASDAQ ... The investment bank said the "sharpness of the correction" of China ICL sales in Q4 and "very modest" outlook for the first half of 2025 was ...

STAAR ICL’s are clinically-proven to deliver safe long-term vision correction without removing corneal tissue or the eye’s natural crystalline lens. Its EVO ICL™ product line provides visual ...

LAKE FOREST, Calif., May 16, 2025--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction ...

Looking ahead, STAAR Surgical anticipates ICL sales outside China to grow by 9-15%, reaching $165-$175 million in FY2025. The company expects China ICL sales to range between $75-$125 million ...

On Wednesday, 04 June 2025, STAAR Surgical ... We’ve had in China, both Toric and Sphere have been approved. So, that was a nice win for us. In Taiwan, the EVO ICL has been approved.

STAAR ICL’s are clinically-proven to deliver safe long-term vision correction without removing corneal tissue or the eye’s natural crystalline lens. Its EVO ICL™ product line provides visual freedom ...

STAAR ICL’s are clinically-proven to deliver safe long-term vision correction without removing corneal tissue or the eye’s natural crystalline lens. Its EVO ICL™ product line provides visual freedom ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...